Product Information
SERTRALINE 20 MG/ML ORAL CONC is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.3650 per ML under NDC 64980040906. Its NADAC has been published 465 times since Nov 8, 2017.
FDA first approved this application on Oct 31, 2008. Its Orange Book therapeutic-equivalence code is AA.
Strength
20 mg/mL
Manufacturer
Rising Pharma Holdings Inc.NDC
64980040906
Classification
Generic
Dosage Form
SOLUTION, CONCENTRATE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SERTRALINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078861FDA Approved
10/31/2008
TE Code
AA
On Market Since
10/31/2008
Pharmacological Classes
Price Statistics
The NADAC for SERTRALINE 20 MG/ML ORAL CONC has been published 465 times since Nov 8, 2017, and over the history we have for it it has declined 51.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3650 per ML |
|---|---|
| All-time high | $0.8075 (Sep 12, 2018) |
| All-time low | $0.3017 (Jul 17, 2024) |
| 52-week high | $0.4582 |
| 52-week low | $0.3650 |
| Median price | $0.5767 |
| Average price | $0.5836 |
| Largest weekly change | +88.0% (Aug 21, 2024) |
| Weeks tracked | 465 |
| Tracking since | Nov 8, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sertraline Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SERTRALINE 20 MG/ML ORAL CONC?
The current National Average Drug Acquisition Cost (NADAC) for SERTRALINE 20 MG/ML ORAL CONC, manufactured by Rising Pharma Holdings Inc., is $0.3650 per ML (NDC 64980040906), effective Sep 30, 2026.
How has the price of SERTRALINE 20 MG/ML ORAL CONC changed over time?
Over the history we have for it, the NADAC for SERTRALINE 20 MG/ML ORAL CONC has declined 51.4%. It has been tracked across 465 weekly CMS publications since Nov 8, 2017.
What are the highest and lowest recorded NADAC prices for SERTRALINE 20 MG/ML ORAL CONC?
Since Nov 8, 2017, the NADAC for SERTRALINE 20 MG/ML ORAL CONC has ranged from a low of $0.3017 (Jul 17, 2024) to a high of $0.8075 (Sep 12, 2018), with a median of $0.5767 per ML.
Are there cheaper alternatives to SERTRALINE 20 MG/ML ORAL CONC?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SERTRALINE 20 MG/ML ORAL CONC in a comparable dosage form, but none are currently priced below it.
Who manufactures SERTRALINE 20 MG/ML ORAL CONC?
SERTRALINE 20 MG/ML ORAL CONC (NDC 64980040906) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.